CF, OCI Amend Merger Agreement to Keep 'Inversion' Tax Benefit -- 2nd Update
22 Dicembre 2015 - 12:10AM
Dow Jones News
By Lisa Beilfuss And Marie Beaudette
Fertilizer maker CF Industries and Dutch rival OCI NV, which
agreed to merge in August, said they would move the tax residency
of the combined company to the Netherlands from the U.K., in a move
to satisfy inversion rules put in place by the U.S. Treasury.
The $8 billion tie-up is a so-called tax-inversion deal that
would create a global nitrogen-fertilizer giant with a
significantly lower tax bill. When the deal was signed,
Illinois-based CF said it would lower its overall tax rate to 20%
from 34% by moving its address to the U.K. In the Netherlands, the
corporate tax rate is 25%.
Inversions have helped drive mergers-and-acquisitions activity
to record highs as companies have looked to foreign deal making for
tax savings. In November, the U.S. Treasury unveiled new rules that
beefed up existing laws governing inversion deals.
They also have drawn criticism from lawmakers and presidential
candidates, and the U.S. Treasury has unveiled new rules twice
since September 2014 meant to curb them.
The latest, in November, snagged CF's deal. It limited the
ability of U.S. firms to "country-shop"--that is, acquire a foreign
target in one country but move to a different one. U.S. firms who
want an inversion deal must now take the address of their foreign
merger partner. That makes inversions harder to do by whittling the
pool of merger partners to those in attractive jurisdictions.
The U.K. has been among the most popular inversion destinations
because American executives are comfortable with its language and
lifestyle and can benefit from its increasingly favorable tax
rules.
The Netherlands, meanwhile, has been criticized for a corporate
rule book that some say tilts too far in favor of management at the
expense of investors. Drugmaker Mylan NV, which relocated to the
Netherlands in February through an inversion, used an unusual
takeover defense to repel a takeover bid from Teva Pharmaceutical
Industries Ltd. last summer, evoking grumbles from some
investors.
Last month, CF said it was committed to the transaction and was
considering taking a Netherlands address.
The Treasury's new rules apply to deals in which the U.S.
company's shareholders end up with more than 60% of the combined
entity. Under the CF and OCI deal, CF shareholders would own more
than 70% of the merged company.
By being a tax resident of the Netherlands, where OCI is
incorporated, the new holding company would satisfy the
requirements of the U.S. Department of the Treasury's notice issued
on Nov. 19, CF said.
Taking the new Treasury rules into account, CF still expects
roughly $500 million in annual cost savings, Chief Executive
Officer Tony Will said on a call with analysts and investors. CF
said the amended merger agreement doesn't affect timing of the
deal's completion, which is expected by mid-2016.
Mr. Will said the combined company would have had profit
generated in the Netherlands taxed at the Dutch tax rate before the
Treasury rules prompted the change of address.
As a result of being a Dutch company, he said, "U.K. profits
will not be double-taxed in the U.S. anymore"--taxed once in the
U.K. and streamed back to the Netherlands. "The U.S. won't have any
claim on being able to tax those profits."
Write to Lisa Beilfuss at lisa.beilfuss@wsj.com
(END) Dow Jones Newswires
December 21, 2015 17:55 ET (22:55 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
Grafico Azioni OCI NV (EU:OCI)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni OCI NV (EU:OCI)
Storico
Da Dic 2023 a Dic 2024